Apyx Medical (APYX)

• Market cap: $33.3M
• 1 day: -2.22%
• 5 days: 4.76%
• 1 month: -21.43%
• 3 months: -44.65%
• 6 months: -26.67%
• Year to date: -44.30%
• 1 year: -38.03%
• 5 years: -75.49%
• 10 years: -86.85%
• Sector: Healthcare
• Industry: Medical Devices

About: Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Employees: 220

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

59% more capital invested

Capital invested by funds: $15.8M [Q3] → $25.1M (+$9.31M) [Q4]

5.42% more ownership

Funds ownership: 36.86% [Q3] → 42.28% (+5.42%) [Q4]

0% more funds holding

Funds holding: 44 [Q3] → 44 (+0) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

20% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 15

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $8K